Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-FR Version v12-FR
Language French French
Date Updated 2019-05-23 2018-06-14
Drug Identification Number 00029149 00029149
Brand name FUNGIZONE INTRAVENOUS INJECTION 50MG FUNGIZONE INTRAVENOUS INJECTION 50MG
Common or Proper name Amphotericin B Amphotericin B
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients AMPHOTERICIN B AMPHOTERICIN B
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size (1 VL) 15 ML (1 VL) 15 ML
ATC code J02AA J02AA
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-05-22 2018-05-28
Actual start date 2018-04-20 2018-04-20
Estimated end date 2019-05-22 2018-10-31
Actual end date 2019-05-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product available Product on allocation.
Health Canada comments